| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A case of cutaneous peripheral T-cell not otherwise specified (PTCL-NOS), successfully treated with brentuximab vedotin after disease progression on standard chemotherapy
|
De Francesco, Irene
|
|
|
156 |
S1 |
p. S57-S58
|
artikel
|
| 2 |
A cross-sectional study examining the diagnosis and psychosocial experiences of patients with cutaneous lymphomas
|
Dren, Natalie
|
|
|
156 |
S1 |
p. S66
|
artikel
|
| 3 |
Aggressive gamma/delta T-cell lymphoma: successful therapy with encapsulated doxorubicin
|
Gosmann, Janika
|
|
|
156 |
S1 |
p. S57
|
artikel
|
| 4 |
Anti-tumor effect of anti-apoptosis clone 11 protein-derived peptides on Sézary syndrome malignant CD4+ T lymphocytes
|
Habault, Justine
|
|
|
156 |
S1 |
p. S14
|
artikel
|
| 5 |
An update on health-related quality of life from the PROCLIPI study
|
Molloy, Kevin
|
|
|
156 |
S1 |
p. S30
|
artikel
|
| 6 |
A rare primary subcutaneous panniculitis-like T-cell lymphoma with scalp involvement associated with lupus panniculitis
|
El Hadadi, Farah
|
|
|
156 |
S1 |
p. S62-S63
|
artikel
|
| 7 |
A retrospective study on diagnostics and treatment outcomes of primary cutaneous B-cell lymphomas
|
Osmancevic, Amra
|
|
|
156 |
S1 |
p. S71
|
artikel
|
| 8 |
Assessing quality of life with ePROMs in patients with cutaneous lymphoma
|
Crooks, Georgia Jane
|
|
|
156 |
S1 |
p. S66-S67
|
artikel
|
| 9 |
Assessing the efficacy of mogamulizumab: a novel tool for the management of mycosis fungoides and Sézary syndrome
|
Wilding, Samuel
|
|
|
156 |
S1 |
p. S17-S18
|
artikel
|
| 10 |
Assessment of skin involvement in cutaneous T-cell lymphoma using convolutional neural networks
|
Walker, Christina J
|
|
|
156 |
S1 |
p. S17
|
artikel
|
| 11 |
Association between primary cutaneous lymphomas and other primary malignancies in patients’ personal or family history in Greek population; a retrospective single-center study
|
Voudouri, Dimitra
|
|
|
156 |
S1 |
p. S68
|
artikel
|
| 12 |
Autologous stem cell transplantation in atypical mycosis fungoides with central nervous system involvement: follow-up
|
Sirsikar, Prachitee
|
|
|
156 |
S1 |
p. S54-S55
|
artikel
|
| 13 |
Bioinformatics insights in etiopathogenesis, diagnosis and therapy of cutaneous T-cell lymphoma
|
Papadaki, Marianna
|
|
|
156 |
S1 |
p. S37-S38
|
artikel
|
| 14 |
Boost of innate immunity cytokines as biomarkers of response to extracorporeal photopheresis in leukemic cutaneous T-cell lymphoma patients
|
Tsai, Yi-Chien
|
|
|
156 |
S1 |
p. S42
|
artikel
|
| 15 |
CD74 overexpression in cutaneous T-cell lymphoma and its inhibition as a potential therapeutic approach
|
Vinh, Katharina
|
|
|
156 |
S1 |
p. S61
|
artikel
|
| 16 |
CD30-positive lymphoproliferations and mycosis fungoides originate from the same T-cell clone and share overlapping oncogenic mutations and gene fusions when occurring in the same patient
|
Wobser, Marion
|
|
|
156 |
S1 |
p. S43
|
artikel
|
| 17 |
Characteristics, management and course of mycosis fungoides in solid organ transplant recipients: a retrospective cohort from two cutaneous lymphoma outpatient clinics
|
Amitay-Laish, Iris
|
|
|
156 |
S1 |
p. S15-S16
|
artikel
|
| 18 |
Characterization and outcomes in patients with mogamulizumab-associated skin reactions in the MAVORIC trial
|
Musiek, Amy C.M.
|
|
|
156 |
S1 |
p. S46
|
artikel
|
| 19 |
Classification of primary cutaneous large B-cell lymphomas according to cell of origin is clinically relevant
|
Gros, Audrey
|
|
|
156 |
S1 |
p. S26-S27
|
artikel
|
| 20 |
Clues for disease progression at time of diagnosis in patients with primary cutaneous follicle center lymphoma
|
Schrader, Anne M.R.
|
|
|
156 |
S1 |
p. S9-S10
|
artikel
|
| 21 |
Combination of ruxolitinib with resminostat exerts antitumor effects in a chick embryo metastasis model
|
Piperi, Christina
|
|
|
156 |
S1 |
p. S40
|
artikel
|
| 22 |
Concomitant use of steroids or phototherapy with chlormethine gel among patients with mycosis fungoides-type cutaneous T-cell lymphoma (MF-CTCL): a real-world evidence study
|
Querfeld, Christiane
|
|
|
156 |
S1 |
p. S44-S45
|
artikel
|
| 23 |
Copyright Page
|
|
|
|
156 |
S1 |
p. iii
|
artikel
|
| 24 |
COVID-19 infection in patients with Sézary syndrome: report of three cases
|
Granara, Martina
|
|
|
156 |
S1 |
p. S69
|
artikel
|
| 25 |
CTCL and pregnancy: great uncertainty and an appeal for prospective clinical research
|
Walker, Christina
|
|
|
156 |
S1 |
p. S33-S34
|
artikel
|
| 26 |
Cutaneous and systemic lymphomas of concordant or discordant B- and T-cell phenotype in the same patient: two case reports
|
Martins, Ana Silva
|
|
|
156 |
S1 |
p. S58
|
artikel
|
| 27 |
Cutaneous T-cell lymphoma (CTCL) exacerbation after viral vector COVID-19 vaccination
|
Panou, Evdoxia
|
|
|
156 |
S1 |
p. S68
|
artikel
|
| 28 |
Cutaneous T-cell lymphoma of mycosis fungoides type with CD30 positive transformation and sweet like neutrophilic dermatosis
|
André, Florine
|
|
|
156 |
S1 |
p. S58-S59
|
artikel
|
| 29 |
Cutaneous T-cell lymphoma patient-derived xenografts retain molecular characteristics across passages
|
Snowden, Caroline
|
|
|
156 |
S1 |
p. S38-S39
|
artikel
|
| 30 |
CXCR4/CXCL12 axis as a potential therapeutic target in mycosis fungoides: an in-vitro study
|
Moyal, Lilach
|
|
|
156 |
S1 |
p. S12
|
artikel
|
| 31 |
Deciphering discrepancies in cutaneous lymphomas genetics
|
Merlio, Jean-Philippe
|
|
|
156 |
S1 |
p. S1-S2
|
artikel
|
| 32 |
Development of EORTC/CLTF questionnaire to assess HRQOL in primary cutaneous T-cell and B-cell lymphomas: phase I
|
Molloy, Kevin
|
|
|
156 |
S1 |
p. S31
|
artikel
|
| 33 |
Diagnostic performance of high throughput sequencing of the T-cell receptor beta gene for the diagnosis of cutaneous T-cell lymphoma
|
de Masson, Adele
|
|
|
156 |
S1 |
p. S1
|
artikel
|
| 34 |
Diagnostics and treatment of mycosis fungoides and Sézary syndrome in West Sweden: a retrospective register-based study of 82 patients
|
Wojewoda, Karolina
|
|
|
156 |
S1 |
p. S67
|
artikel
|
| 35 |
Dimethyl fumarate (DMF) therapy in CTCL: results from a clinical phase II study
|
Nicolay, Jan P.
|
|
|
156 |
S1 |
p. S21-S22
|
artikel
|
| 36 |
Editorial Board
|
|
|
|
156 |
S1 |
p. ii
|
artikel
|
| 37 |
Efficacy of mogamulizumab in mycosis fungoides by patient blood involvement and time to response analysis in mycosis fungoides and Sézary syndrome: a post hoc analysis of the MAVORIC study
|
Beylot-Barry, Marie
|
|
|
156 |
S1 |
p. S47-S48
|
artikel
|
| 38 |
Enhancement of antibody-dependent cellular cytotoxicity is associated with treatment response to extracorporeal photopheresis in Sézary syndrome
|
Iselin, Christoph
|
|
|
156 |
S1 |
p. S7
|
artikel
|
| 39 |
EORTC-QLQ-C30 and SKINDEX-29 measurement of health-related quality of life in patients with mycosis fungoides and Sézary syndrome: real-world data in Spanish patients (MICADOS study)
|
del Mar Onteniente Gomis, María
|
|
|
156 |
S1 |
p. S29-S30
|
artikel
|
| 40 |
Epidemiology of primary cutaneous lymphomas in Greece: a 12-year retrospective study
|
Kaliampou, Stella
|
|
|
156 |
S1 |
p. S67-S68
|
artikel
|
| 41 |
Epigenetic modifiers can alter telomerase expression and clonogenic capacities of Sézary cells
|
Chebly, Alain
|
|
|
156 |
S1 |
p. S7-S8
|
artikel
|
| 42 |
Evaluation of haematopoietic stem cell transplantation in patients diagnosed with cutaneous T cell lymphoma at a tertiary care centre
|
Applewaite, Rona
|
|
|
156 |
S1 |
p. S55
|
artikel
|
| 43 |
Evaluation of mir-146a and mir-155 plasma expression levels in patients with mycosis fungoides and detection of single nucleotide polymorphisms in their sequence
|
Avgeros, Chrysostomos
|
|
|
156 |
S1 |
p. S39
|
artikel
|
| 44 |
Evaluation of the PCR-based T cell receptor-β clonality test in the diagnosis of early mycosis fungoides
|
Barzilai, Aviv
|
|
|
156 |
S1 |
p. S60-S61
|
artikel
|
| 45 |
Evaluation of the role of different cell populations in mycosis fungoides microenvironment as a tool for biomarker identification for disease progression and individualized therapy
|
Pavlidis, Antreas
|
|
|
156 |
S1 |
p. S40-S41
|
artikel
|
| 46 |
Experience of a supra-regional cutaneous lymphoma centre during the COVID-19 pandemic
|
Nguyen, Uyen
|
|
|
156 |
S1 |
p. S27-S28
|
artikel
|
| 47 |
Exploratory comparative transcriptomic analysis of CD8+ mycosis fungoides and type D lymphomatoid papulosis
|
Argyropoulos, Kimon
|
|
|
156 |
S1 |
p. S5
|
artikel
|
| 48 |
Exploring the role of the skin microenvironment in cutaneous T-cell lymphoma using single cell RNA-sequencing
|
Dobos, Gabor
|
|
|
156 |
S1 |
p. S3-S4
|
artikel
|
| 49 |
Extracorporeal photopheresis during the COVID-19 pandemic: experience in Argentina
|
Baquero Rey, Jenny Andrea
|
|
|
156 |
S1 |
p. S55-S56
|
artikel
|
| 50 |
Extracorporeal photopheresis in varying mycosis fungoides and Sézary syndrome stages: race-based differences in treatment utilization and response
|
Kumar, Priyanka
|
|
|
156 |
S1 |
p. S35
|
artikel
|
| 51 |
Flow-cytometry and functional evaluation of the CD39/CD73 adenosinergic immunosuppressive axis in patients with Sézary syndrome
|
Quaglino, Pietro
|
|
|
156 |
S1 |
p. S12-S13
|
artikel
|
| 52 |
French real-life retrospective study in patients with mycosis fungoides and Sezary syndrome treated by mogamulizumab
|
Beylot-Barry, Marie
|
|
|
156 |
S1 |
p. S59-S60
|
artikel
|
| 53 |
Functional remodeling of macrophages with anti-PD-L1 and lenalidomide in cutaneous T cell lymphoma
|
Han, Zhen
|
|
|
156 |
S1 |
p. S15
|
artikel
|
| 54 |
Genetic expression profile in the prognosis of mycosis fungoides
|
Moneva, Vanessa Gargallo
|
|
|
156 |
S1 |
p. S37
|
artikel
|
| 55 |
Granulomatous rash associated with mogamulizumab mimicking mycosis fungoides: a case series
|
Wang, Jingying
|
|
|
156 |
S1 |
p. S49
|
artikel
|
| 56 |
Granulomatous slack skin: clinical retrospective study of 8 cases of the Cutaneous Lymphoma French Study Group
|
Battesti, Gilles
|
|
|
156 |
S1 |
p. S35-S36
|
artikel
|
| 57 |
Health-related quality of life effect of mogamulizumab by patient blood involvement
|
Zinzani, Pier Luigi
|
|
|
156 |
S1 |
p. S65-S66
|
artikel
|
| 58 |
High intraindividual variability of CD30 expression in mycosis fungoides: implications for diagnostic evaluation and therapy
|
Mitteldorf, Christina
|
|
|
156 |
S1 |
p. S26
|
artikel
|
| 59 |
High PD1 expression H score is associated with Sézary diagnosis: study of 91 patients with erythroderma
|
Luherne, Camille
|
|
|
156 |
S1 |
p. S24-S25
|
artikel
|
| 60 |
High resolution integrated genomic analyses of distinct clinical entities within cutaneous T-cell lymphomas
|
Bastidas Torres, Armando Nicolas
|
|
|
156 |
S1 |
p. S42-S43
|
artikel
|
| 61 |
ICOS is widely expressed in cutaneous T-cell lymphoma and its targeting promotes potent killing of malignant cells
|
Amatore, Florent
|
|
|
156 |
S1 |
p. S23-S24
|
artikel
|
| 62 |
Ifosfamide and etoposide in advanced-stage, relapsed or refractory primary cutaneous T-cell lymphomas
|
de Masson, Adele
|
|
|
156 |
S1 |
p. S22
|
artikel
|
| 63 |
Image-guided lymph node core-needle biopsy predicts survival in mycosis fungoides and Sézary syndrome
|
Calvani, Julien
|
|
|
156 |
S1 |
p. S26
|
artikel
|
| 64 |
Improved Sézary cell detection and novel insights into immunophenotypic and molecular heterogeneity in Sézary syndrome
|
Najidh, Safa
|
|
|
156 |
S1 |
p. S6
|
artikel
|
| 65 |
Incidence and mortality of cutaneous lymphoma in North-Rhine Westphalia/Germany: recent trends and data of the population-based cancer registry of North Rhine Westphalia
|
El Najjarine, Khodr Cheikh
|
|
|
156 |
S1 |
p. S33
|
artikel
|
| 66 |
Incidence of mycosis fungoides and Sézary syndrome in the Netherlands in the last two decades
|
Ottevanger, Rosanne
|
|
|
156 |
S1 |
p. S32
|
artikel
|
| 67 |
Increased chlormethine induced DNA double stranded breaks in malignant T cells from mycosis fungoides skin lesions
|
Chang, Yun-Tsan
|
|
|
156 |
S1 |
p. S11
|
artikel
|
| 68 |
Indolent primary cutaneous T-cell gamma delta lymphomas: a first illustrated series of 5 cases
|
Galadari, Alia
|
|
|
156 |
S1 |
p. S70-S71
|
artikel
|
| 69 |
International Cutaneous Lymphomas Pandemic Section (ICLYPS) analysis of CTCL outcomes during COVID-19
|
Geskin, Larisa J
|
|
|
156 |
S1 |
p. S32-S33
|
artikel
|
| 70 |
Interviews with patients and their spouses to capture personal descriptions of early treatment experience with mogamulizumab for mycosis fungoides (MF) and Sézary syndrome (SS)
|
Gibson, Jane
|
|
|
156 |
S1 |
p. S64
|
artikel
|
| 71 |
Intravascular relapse of an extra-nodal NK/T-cell lymphoma, nasal-type, presenting as diffuse and eruptive telangiectasia
|
Battesti, Gilles
|
|
|
156 |
S1 |
p. S63-S64
|
artikel
|
| 72 |
Is mogamulizumab-induced alopecia areata associated with favorable outcomes in Sézary syndrome?
|
Amatore, Florent
|
|
|
156 |
S1 |
p. S50-S51
|
artikel
|
| 73 |
Lacutamab in patients (pts) with advanced mycosis fungoides (MF) according to KIR3DL2 expression: early results from the TELLOMAK phase 2 trial
|
Bagot, Martine
|
|
|
156 |
S1 |
p. S20-S21
|
artikel
|
| 74 |
Large cell transformation is an independent prognostic factor in Sézary syndrome: a retrospective analysis of 117 cases
|
Bontoux, Christophe
|
|
|
156 |
S1 |
p. S25
|
artikel
|
| 75 |
Macrophage-derived CXCL9 and CXCL11 recruit CD8 T cells in skin and provide long-term disease control in mogamulizumab-treated CTCL patients
|
de Masson, Adèle
|
|
|
156 |
S1 |
p. S19-S20
|
artikel
|
| 76 |
Macular type of primary cutaneous B-cell lymphoma: extension of the clinical and histopathological patterns
|
Barzilai, Aviv
|
|
|
156 |
S1 |
p. S27
|
artikel
|
| 77 |
Maintenance therapy with chlormethine gel among patients with mycosis fungoides-type cutaneous T-cell lymphoma (MF-CTCL): a real-world evidence study
|
Querfeld, Christiane
|
|
|
156 |
S1 |
p. S45
|
artikel
|
| 78 |
Mass cytometry and machine learning delineate tumor-defining cells in Sézary syndrome to allow discrimination from benign erythroderma
|
Carl, Sarah Hamilton
|
|
|
156 |
S1 |
p. S5-S6
|
artikel
|
| 79 |
Mechanisms of resistance to anti-CCR4 antibody, mogamulizumab, in cutaneous T cell lymphoma
|
Beygi, Sara
|
|
|
156 |
S1 |
p. S8
|
artikel
|
| 80 |
miRNA signature in early-stage mycosis fungoides
|
Sørensen, Sissel T
|
|
|
156 |
S1 |
p. S4
|
artikel
|
| 81 |
Mode-of-action of HDAC inhibitor resminostat in CTCL
|
Streubel, Gundula
|
|
|
156 |
S1 |
p. S39-S40
|
artikel
|
| 82 |
Mogalizumab-induced granulomatous eruption of the scalp: a distinct entity associated with clinical response?
|
Pham-Ledard, Anne
|
|
|
156 |
S1 |
p. S49-S50
|
artikel
|
| 83 |
Mogamulizumab-associated rash frequently mimics cutaneous T-cell lymphoma recurrence but heralds a positive response to therapy: an updated single-center case series
|
Trum, Nicholas A.
|
|
|
156 |
S1 |
p. S19
|
artikel
|
| 84 |
Mogamulizumab in a patient with Sézary syndrome and severe atopic dermatitis
|
Amatore, Florent
|
|
|
156 |
S1 |
p. S51-S52
|
artikel
|
| 85 |
Mogamulizumab-induced vitiligo: 3 cases
|
De Masson, Adele
|
|
|
156 |
S1 |
p. S50
|
artikel
|
| 86 |
Mogamulizumab induces long term immune restoration and reshapes tumoral heterogeneity in Sézary syndrome
|
Roelens, Marie
|
|
|
156 |
S1 |
p. S19
|
artikel
|
| 87 |
Mutational landscape of nodal peripheral T-cell lymphoma subtypes
|
Tomas-Roca, Laura
|
|
|
156 |
S1 |
p. S9
|
artikel
|
| 88 |
Nanostring analysis of mycosis fungoides offers clues to better understand MF pathogenesis and progression
|
Alonso, Ruth Alonso
|
|
|
156 |
S1 |
p. S3
|
artikel
|
| 89 |
New insights into granulomatous mycosis fungoides (GMF): a single-center experience
|
Sidiropoulou, Polytimi
|
|
|
156 |
S1 |
p. S69-S70
|
artikel
|
| 90 |
Occurrence of Sézary syndrome following the initiation of anti-IL-5 drug
|
Barré, Mathilde
|
|
|
156 |
S1 |
p. S41-S42
|
artikel
|
| 91 |
Papuloerythroderma of Ofuji successfully treated with oral retinoids
|
Blanchard, Gabriela
|
|
|
156 |
S1 |
p. S56-S57
|
artikel
|
| 92 |
Patient characteristics of long-term responders to mogamulizumab: results from the MAVORIC study
|
Kim, Youn H.
|
|
|
156 |
S1 |
p. S48-S49
|
artikel
|
| 93 |
PD1 in Sézary syndrome: a repressor of cell survival sometimes lost during progression, but a new target using depleting antibodies?
|
Decroos, Amandine
|
|
|
156 |
S1 |
p. S14-S15
|
artikel
|
| 94 |
PD1 regulates T cell exhaustion phenotypes and disease aggressiveness in CTCL
|
Daniels, Jay
|
|
|
156 |
S1 |
p. S2-S3
|
artikel
|
| 95 |
Pegylated-interferon as an alternative to interferon-alfa 2a in cutaneous T-cell lymphoma
|
Iype, Rohan
|
|
|
156 |
S1 |
p. S53
|
artikel
|
| 96 |
Peripheral T-cell lymphoma: molecular profiling distinguishes subclasses, recognizes the tumor architecture and identifies prognostic markers
|
Rodriguez-Moreno, Marta
|
|
|
156 |
S1 |
p. S43-S44
|
artikel
|
| 97 |
Phase II trial evaluating resminostat for maintenance treatment of patients with advanced stage (stage IIB–IVB) mycosis fungoides (MF) or Sézary syndrome (SS): RESMAIN study
|
Stadler, Rudolf
|
|
|
156 |
S1 |
p. S53-S54
|
artikel
|
| 98 |
Phase II trial of atezolizumab (anti-PD-L1) in the treatment of stage IIb–IVB mycosis fungoides/Sézary syndrome patients relapsed/refractory after a previous systemic treatment (PARCT)
|
Stadler, Rudolf
|
|
|
156 |
S1 |
p. S22-S23
|
artikel
|
| 99 |
Phototherapy-induced interferon kappa drives type I interferon mediated anticancer responses in cutaneous T cell lymphoma
|
Yu, Zizi
|
|
|
156 |
S1 |
p. S21
|
artikel
|
| 100 |
PLCγ1/PKCθ and its downstream effectors in cutaneous T-cell lymphoma development and progression
|
García-Diaz, Nuria
|
|
|
156 |
S1 |
p. S4-S5
|
artikel
|
| 101 |
Preclinical investigation of new targeted combination therapies in cutaneous T-cell lymphoma
|
Şener, Özge Çiçek
|
|
|
156 |
S1 |
p. S44
|
artikel
|
| 102 |
Primary cutaneous B-cell lymphoma leg-type related to an anti-TNF-alpha therapy
|
Belkaid, Samy
|
|
|
156 |
S1 |
p. S59
|
artikel
|
| 103 |
Primary cutaneous B-cell lymphomas in children and adolescents: a SEER population-based study
|
Goldberg, Ilan
|
|
|
156 |
S1 |
p. S36
|
artikel
|
| 104 |
Primary cytotoxic T cell lymphomas harbor recurrent targetable alterations in the JAK-STAT pathway
|
Lee, Katie
|
|
|
156 |
S1 |
p. S8-S9
|
artikel
|
| 105 |
Prognostic factors in mycosis fungoides and Sézary syndrome: results from the PROCLIPI study
|
Scarisbrick, Julia J.
|
|
|
156 |
S1 |
p. S28-S29
|
artikel
|
| 106 |
Prognostic value of the clonal rearrangement of T-cell receptor genes detection in the bone marrow in patients with mycosis fungoides
|
Gorenkova, Liliya
|
|
|
156 |
S1 |
p. S37
|
artikel
|
| 107 |
Psoriasis-like eruption and arthritis secondary to mogamulizumab in a patient with Sézary syndrome
|
Combalia, Andrea
|
|
|
156 |
S1 |
p. S51
|
artikel
|
| 108 |
Psychological aspects and coping strategies in patients with mycosis fungoides
|
Goldberg, Ilan
|
|
|
156 |
S1 |
p. S64-S65
|
artikel
|
| 109 |
Pustular mycosis fungoides has a poor outcome: a clinico-pathological and longitudinal study of 36 cases
|
Badrignans, Marine
|
|
|
156 |
S1 |
p. S23-S24
|
artikel
|
| 110 |
Quality of life in patients with mycosis fungoides and Sézary syndrome: a review of the literature
|
Ottevanger, Rosanne
|
|
|
156 |
S1 |
p. S65
|
artikel
|
| 111 |
Quantifying response to various treatments using the revisited blood staging of mycosis fungoides and Sézary syndrome with the KIR3DL2 marker
|
Dobos, Gabor
|
|
|
156 |
S1 |
p. S6-S7
|
artikel
|
| 112 |
Quantitative IHC analyses for CD30+ cutaneous T-cell lymphoma: chances and challenges
|
Cieslak, Cassandra
|
|
|
156 |
S1 |
p. S61
|
artikel
|
| 113 |
Racial differences in clinical presentation and outcomes in mycosis fungoides and Sézary syndrome in the United States: a large singe center retrospective analysis
|
Allen, Pamela Blair
|
|
|
156 |
S1 |
p. S34
|
artikel
|
| 114 |
Real world data shows that chlormethine gel is efficient and safe in mycosis fungoides skin lesions
|
Papadavid, Evangelia
|
|
|
156 |
S1 |
p. S16
|
artikel
|
| 115 |
Response to brentuximab vedotin in advanced stage MF/Sézary syndrome with low CD-30 expression: “real-life” data of the German Cutaneous Lymphoma Network
|
Blazejak, Christoph
|
|
|
156 |
S1 |
p. S16-S17
|
artikel
|
| 116 |
Retrospective analysis of standard-of-care imaging in patients with cutaneous T-cell lymphoma
|
Garcia-Saleem, Tiffany J
|
|
|
156 |
S1 |
p. S45-S46
|
artikel
|
| 117 |
Secretomic and proteomic analysis of cutaneous T cell lymphoma-associated fibroblasts
|
Boismal, Françoise
|
|
|
156 |
S1 |
p. S5
|
artikel
|
| 118 |
Single-cell RNA sequencing reveals markers of disease progression in primary cutaneous T-cell lymphoma
|
Rindler, Katharina
|
|
|
156 |
S1 |
p. S38
|
artikel
|
| 119 |
Single-center experience of using pegylated liposomal doxorubicin as maintenance therapy in mycosis fungoides
|
Falkenhain-López, Daniel
|
|
|
156 |
S1 |
p. S54
|
artikel
|
| 120 |
Spectrum of dermo-epidermic cutaneous gamma-delta lymphomas from a single center: clinical and phenotypic analysis of an heterogenous lymphoproliferative disorder
|
Violetti, Silvia Alberti
|
|
|
156 |
S1 |
p. S63
|
artikel
|
| 121 |
Subtype-specific differences in the genomic landscape of cutaneous T cell lymphomas
|
Park, Joonhee
|
|
|
156 |
S1 |
p. S2
|
artikel
|
| 122 |
Sézary syndrome shows whole genome duplication as a late event in tumor evolution
|
Hain, Carsten
|
|
|
156 |
S1 |
p. S41
|
artikel
|
| 123 |
Table of Contents
|
|
|
|
156 |
S1 |
p. iv
|
artikel
|
| 124 |
Targeted sequencing of mycosis fungoides with large cell transformation
|
Wobser, Marion
|
|
|
156 |
S1 |
p. S25-S26
|
artikel
|
| 125 |
The primary cutaneous CD30- positive lymphoproliferative diseases; the own observations of the center, prospects of therapy
|
Gorenkova, Liliya
|
|
|
156 |
S1 |
p. S55-S56
|
artikel
|
| 126 |
The role of illness perception in patients with cutaneous T-cell lymphoma
|
Eseonu, Amarachi
|
|
|
156 |
S1 |
p. S31
|
artikel
|
| 127 |
The use of pegylated interferon a-2a in a cohort of Greek patients with mycosis fungoides
|
Patsatsi, Aikaterini
|
|
|
156 |
S1 |
p. S52-S53
|
artikel
|
| 128 |
The use of small doses of gemcitabine in the treatment of drug-resistant forms of mycosis fungoides/Sézary syndrome
|
Gorenkova, Liliya
|
|
|
156 |
S1 |
p. S54
|
artikel
|
| 129 |
Time-to-next-treatment and time-to-next-systemic treatment in patients included in the PROCLIPI registry
|
Quaglino, Pietro
|
|
|
156 |
S1 |
p. S28
|
artikel
|
| 130 |
Title Page
|
|
|
|
156 |
S1 |
p. i
|
artikel
|
| 131 |
Toll-like receptor 4 activity promotes immunosuppression in the cutaneous T-cell lymphoma microenvironment
|
Shah, Brinda
|
|
|
156 |
S1 |
p. S39
|
artikel
|
| 132 |
Topical mechlorethamine in mycosis fungoides: a prospective clinical, histopathological, and molecular analysis of 13 cases
|
Sidiropoulou, Polytimi
|
|
|
156 |
S1 |
p. S61-S62
|
artikel
|
| 133 |
Treatment efficacy for Sézary syndrome: an international, multi-centre, comparative study of current systemic therapies
|
Campbell, Belinda A
|
|
|
156 |
S1 |
p. S20
|
artikel
|
| 134 |
Understanding relative survival outcomes for patients with cutaneous T-cell lymphoma (CTCL) subtypes mycosis fungoides and Sézary syndrome treated with mogamulizumab or vorinostat: combining Australian real-world evidence and MAVORIC phase 3 trial data
|
Remák, Edit
|
|
|
156 |
S1 |
p. S18
|
artikel
|
| 135 |
Understanding the function of CD30 in cutaneous T-cell lymphoma: implications for therapy and prognosis
|
Albrecht, Jana Dorothea
|
|
|
156 |
S1 |
p. S11-S12
|
artikel
|
| 136 |
Use of mogamulizumab for refractory Sézary syndrome in real clinical practice: report of three cases
|
Navarro, Irene Navarro
|
|
|
156 |
S1 |
p. S46-S47
|
artikel
|
| 137 |
Vindesine dexamethasone as a therapeutic option in elderly blastic plasmacytoid dendritic cell neoplasms: a monocentric experience
|
Benarfa, Alyssa
|
|
|
156 |
S1 |
p. S59-S60
|
artikel
|
| 138 |
Xenograft and cell culture models of Sézary syndrome reveal cell of origin diversity and subclonal heterogeneity
|
Poglio, Sandrine
|
|
|
156 |
S1 |
p. S11
|
artikel
|
Tijdschrift beschrijving